1. Home
  2. BDSX vs QUAD Comparison

BDSX vs QUAD Comparison

Compare BDSX & QUAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • QUAD
  • Stock Information
  • Founded
  • BDSX 2005
  • QUAD 1971
  • Country
  • BDSX United States
  • QUAD United States
  • Employees
  • BDSX 217
  • QUAD N/A
  • Industry
  • BDSX Precision Instruments
  • QUAD Publishing
  • Sector
  • BDSX Health Care
  • QUAD Consumer Discretionary
  • Exchange
  • BDSX Nasdaq
  • QUAD Nasdaq
  • Market Cap
  • BDSX 245.3M
  • QUAD 233.2M
  • IPO Year
  • BDSX 2020
  • QUAD 2010
  • Fundamental
  • Price
  • BDSX $1.65
  • QUAD $4.91
  • Analyst Decision
  • BDSX Strong Buy
  • QUAD Strong Buy
  • Analyst Count
  • BDSX 4
  • QUAD 2
  • Target Price
  • BDSX $3.08
  • QUAD $8.05
  • AVG Volume (30 Days)
  • BDSX 239.8K
  • QUAD 141.4K
  • Earning Date
  • BDSX 11-05-2024
  • QUAD 10-29-2024
  • Dividend Yield
  • BDSX N/A
  • QUAD 4.02%
  • EPS Growth
  • BDSX N/A
  • QUAD N/A
  • EPS
  • BDSX N/A
  • QUAD N/A
  • Revenue
  • BDSX $60,902,000.00
  • QUAD $2,777,100,000.00
  • Revenue This Year
  • BDSX $48.06
  • QUAD N/A
  • Revenue Next Year
  • BDSX $29.97
  • QUAD N/A
  • P/E Ratio
  • BDSX N/A
  • QUAD N/A
  • Revenue Growth
  • BDSX 46.25
  • QUAD N/A
  • 52 Week Low
  • BDSX $1.15
  • QUAD $3.96
  • 52 Week High
  • BDSX $2.21
  • QUAD $6.75
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 45.54
  • QUAD 63.55
  • Support Level
  • BDSX $1.67
  • QUAD $4.47
  • Resistance Level
  • BDSX $1.80
  • QUAD $4.76
  • Average True Range (ATR)
  • BDSX 0.07
  • QUAD 0.23
  • MACD
  • BDSX -0.01
  • QUAD 0.06
  • Stochastic Oscillator
  • BDSX 42.31
  • QUAD 82.89

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market.

Share on Social Networks: